# A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.

> **NCT07198555** · PHASE1 · RECRUITING · sponsor: **Belief BioMed (Beijing) Co., Ltd** · enrollment: 81 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** BBM-A101
- **DRUG:** Placebo
- **DRUG:** BBM-A101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07198555
- **Lead sponsor:** Belief BioMed (Beijing) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-09
- **Primary completion:** 2027-12-30
- **Final completion:** 2031-12-30
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07198555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07198555, "A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07198555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*